Ethical Conflict in Providing Informed Consent for Clinical Trials: A Problematic Example from the Gynecologic Cancer Research Community

Ethical Conflict in Providing Informed Consent for Clinical Trials: A Problematic Example from the Gynecologic Cancer Research Community Maurie Markman Oncologist 2004; 9: 3-7 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine and medical ethics, and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Describe the importance of the informed consent process in clinical trials. Discuss the implications of the randomized phase III trial of maintenance paclitaxel chemotherapy in advanced ovarian cancer. Explain the responsibilities of clinical investigators and clinicians to inform their patients of new results that may affect their willingness to participate in clinical trials. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Jan. 30, 2004 Most Recent Review: Jan. 30, 2004* Most Recent Update: Jan. 30, 2004 Date Credit Expires: Apr. 10, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.